| scholarly article | Q13442814 |
| P2093 | author name string | Jing Wang | |
| Jacqueline Jonklaas | |||
| Jang Cho | |||
| Michael Glicksman | |||
| Matthew D'Antuono | |||
| P2860 | cites work | Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells | Q21245299 |
| Genetics, pathogenesis and clinical interventions in type 1 diabetes | Q28281029 | ||
| Diagnosis and classification of diabetes mellitus | Q28299875 | ||
| Human mesenchymal stem cells modulate B-cell functions | Q29620705 | ||
| Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. | Q30478228 | ||
| Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future | Q30597265 | ||
| Why Do SGLT2 inhibitors inhibit only 30-50% of renal glucose reabsorption in humans? | Q33354192 | ||
| Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells | Q34233041 | ||
| In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion | Q34967985 | ||
| Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity | Q35976735 | ||
| Potential of mesenchymal stem cell therapy | Q36956125 | ||
| Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results | Q37255164 | ||
| Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells. | Q38169550 | ||
| Shielding Engineered Islets With Mesenchymal Stem Cells Enhance Survival Under Hypoxia | Q39015256 | ||
| Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study | Q40321403 | ||
| Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus | Q43290819 | ||
| Effect of combined therapy of human Wharton's jelly-derived mesenchymal stem cells from umbilical cord with sitagliptin in type 2 diabetic rats | Q43648419 | ||
| Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells | Q44536342 | ||
| Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells | Q44691263 | ||
| Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study. | Q46963062 | ||
| Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells | Q47126440 | ||
| Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. | Q51034470 | ||
| Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells. | Q51055565 | ||
| Adipose-derived mesenchymal stem cells ameliorate hyperglycemia through regulating hepatic glucose metabolism in type 2 diabetic rats. | Q51237816 | ||
| Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells. | Q51788795 | ||
| Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats. | Q51804359 | ||
| Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats. | Q53292370 | ||
| Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype | Q56902900 | ||
| Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study | Q58634190 | ||
| Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals | Q62083511 | ||
| P433 | issue | 4 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| type 2 diabetes | Q3025883 | ||
| stem cell transplantation | Q65592366 | ||
| P304 | page(s) | 82-93 | |
| P577 | publication date | 2018-10-01 | |
| P1433 | published in | American Journal of Stem Cells | Q27724047 |
| P1476 | title | A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus | |
| P478 | volume | 7 |
| Q64062244 | A Systematic Review of Phytochemistry, Pharmacology and Pharmacokinetics on Radix: Implications for Radix as a Personalized Medicine |
| Q90236280 | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy |
| Q96647453 | Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections |
| Q64235971 | Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account? |
| Q64057195 | Clinical Potential and Current Progress of Dental Pulp Stem Cells for Various Systemic Diseases in Regenerative Medicine: A Concise Review |
| Q96128531 | Depletion of the diabetic gut microbiota resistance enhances stem cells therapy in type 1 diabetes mellitus |
Search more.